Lymphotoxins: new targets for hepatocellular carcinoma In this issue of Cancer Cell, Haybaeck et al unravel the role of lymphotoxin pathway in the development of hepatocellular carcinoma (HCC). Aberrant activation of this cascade in mice livers recapitulates the stages of fibrosis and inflammation that precedes human liver cancer, providing a novel family of potential therapeutic targets. 